Real-world evidence of effectiveness and safety of pasireotide in the treatment of acromegaly: a systematic review and meta-analysis (NOV, 10.1007/s11154-024-09928-3, 2024)
Por:
Biagetti, B, Araujo-Castro, M, Tebe, C, Marazuela, M and Puig-Domingo, M
Publicada:
27 nov 2024
Ahead of Print:
1 nov 2024
Resumen:
Filiaciones:
Biagetti, B:
Hosp Univ Vall Hebron, Endocrinol & Nutr Dept, CIBERER U747, ISCIII,ENDO ERN, Barcelona, Spain
Araujo-Castro, M:
Hosp Univ Ramon y Cajal, Inst Invest Biomed Ramon y Cajal IRYCIS, Dept Endocrinol & Nutr, Madrid, Spain
:
Germans Trias & Pujol Res Inst & Hosp IGTP, Biostat Support & Res Unit, Badalona, Spain
Marazuela, M:
Hosp Univ La Princesa Madrid, Endocrinol & Nutr Dept, Madrid, Spain
:
Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Endocrinol & Nutr Dept, CIBERER U747,ISCIII, Badalona, Spain
hybrid
|